UNH lifts 2026 guidance to $20.50, trades 18.8% below target
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
UnitedHealth Group has raised its adjusted 2026 earnings guidance to at least $20.50 per share following strong third-quarter results that surpassed analyst expectations. The company's stock saw a 1.70 percent gain, trading at EUR 364.70 at Lang & Schwarz. This positive outlook is supported by an improved medical care ratio and a recent target increase by JPMorgan.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.